ENT

Your Article Summary

See Latest Articles

Survival for ethmoid sinus adenocarcinoma in European populations
Acta Oncologica, 09/21/09

Gatta G et al. – Since no survival improvement with time was evident from this study, efforts should be made to improve early diagnosis. GPs and ENT specialists should be alerted to the disease and encouraged to take occupational histories in people with persistent nasal symptoms, which may lead to a reasonable suspicion of malignancy. Monitoring of exposed workers may also improve early diagnosis. Patients with suspected ethmoid cancer should be referred immediately a specialized diagnosis and treatment centre.

Today in Head and Neck...keeping you current

Receive free subspecialty "5-minute updates" via email

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial
Journal of Clinical Oncology, 11/25/09

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09

See All of Head and Neck

Today in Sinus...keeping you current

Receive free subspecialty "5-minute updates" via email

Bone chip-induced rhinosinusitis
The Laryngoscope, 11/02/09

Characterization of initial clinical symptoms and risk factors for sinonasal adenocarcinomas: results of a case-control study
International Archives of Occupational & Environmental Health, 11/06/09

Endonasal Endoscopic Management of Contact Point Headache and Diagnostic Criteria
Headache: The Journal of Head and Face Pain, 10/07/09

See All of Sinus